265: From Human Variability to Automated Precision: Accelerating Cell and Gene Therapy Manufacturing Scale-Out with Farlan Veraitch - Part 1

What if the simple act of opening an incubator could undermine the consistency of your cell therapy manufacturing process? Unlike traditional biologics, the moment cells leave their incubator, subtle shifts in temperature, CO₂, and pH can spiral into mission-critical variability, jeopardizing everything from product yield to therapeutic potency.This episode features Farlan Veraitch, founder and Chief Scientific Officer of Ori Biotech. Trained at UCL’s Department of Biochemical Engineering, Farlan blends a bioprocess engineer’s mindset with hands-on experience scaling monoclonal antibodies, before pioneering the first-ever automation platform for embryonic stem cell culture. His drive for eliminating variability and designing systems that scale seamlessly from bench to bedside has informed ORI’s approach to modular cell therapy manufacturing.What you’ll hear in this episode:The importance of controlling pH, temperature, and shear forces in cell therapy manufacturing (00:36)Lessons learned from scaling monoclonal antibody production and its impact on biotech business models (05:23)The unique sources of variability in primary and stem cells, and why automation is essential (11:16)Strategies to minimize human-induced variability in sensitive cell cultures (12:59)How exposure to ambient oxygen and CO₂ during manual processing affects cell viability (14:13)The logic behind Ori Biotech’s modular design to solve environmental control issues (19:04)Strategic insight:As cell and gene therapies push boundaries, manufacturing must keep pace with exponentially tighter requirements. Farlan’s journey highlights a universal lesson for scientists and engineers: process control is not just a technicality, but a necessity for reproducible, scalable, and commercially viable therapies.If you’re grappling with process variability or looking for fresh strategies in cell and gene therapy development, this episode offers an inside view from a scientist who’s worked at the intersection of bioprocess, automation, and commercial translation.Connect with Farlan Veraitch:LinkedIn: www.linkedin.com/in/farlan-singh-veraitch-a677112Email: [email protected] Biotech: www.oribiotech.comNext step:Need fast CMC guidance? → Get rapid CMC decision support hereSupport the show